体内表达矢量化抗体市场(关键地区、市场参与者、规模和份额)-到 2031 年的预测

  • Report Code : TIPRE00027649
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

体内表达载体抗体市场预计在 2023 年至 2031 年期间的复合年增长率为 13.4%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告按技术(腺相关病毒 (AAV) 载体、电穿孔、脂质纳米颗粒 (LNP))进行细分。报告按最终用户(研究机构、医院、其他)进行细分。全球分析进一步细分为区域和主要国家。报告以美元为单位提供上述分析和细分的价值。

报告目的

Insight Partners 撰写的《体内表达载体抗体市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

用于体内表达的矢量化抗体市场细分

 

技术

  • 腺相关病毒载体
  • 电穿孔
  • 脂质纳米颗粒

最终用户

  • 研究所
  • 医院
  • 其他的

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

用于体内表达的矢量化抗体市场:战略洞察

Vectorized Antibodies for In Vivo Expression Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

用于体内表达的矢量化抗体市场增长动力

  • 基因传递系统的新科学创新:构建更高效、更安全的基因传递系统的进步是喷射载体市场的主要驱动力。将工程遗传物质插入靶细胞的技术已经多样化,包括病毒载体(慢病毒、腺病毒和腺相关病毒)和非病毒方法(脂质体、纳米颗粒和电穿孔),并且能够直接在体内精确、持续地表达治疗性抗体,而无需体外生产、纯化和施用抗体。
  • 个性化医疗的新兴市场:矢量化抗体领域的另一个重要驱动因素是个性化医疗。这种体内表达技术通过将患者自身的遗传物质输送到体内,提供更加针对患者的治疗。这尤其适用于单克隆抗体或工程疗法,其中个体患者的遗传会影响治疗反应和结果。因此,矢量化抗体将成为设计和制造更加个性化和有针对性的疗法的解决方案之一,尤其是针对癌症等复杂疾病。
  • 降低制造成本:生产此类抗体的传统方法(如细胞培养)需要昂贵且耗时的制造设施。体内表达的载体化抗体为以较低成本生产抗体提供了一种有前途的替代方法。它的优点是完全避免了繁琐的体外生产纯化过程,并降低了总体制造成本,不仅增加了扩大治疗的可用性,而且使抗体疗法变得可负担得起,尤其是对于较小剂量或罕见疾病的治疗。

体内表达载体抗体市场未来趋势

  • 癌症免疫疗法的使用增加:这种癌症免疫疗法趋势对于推动创新抗体治疗市场非常重要。载体化的抗体专门针对肿瘤特异性抗原或调节免疫反应,是开发更有效、更持久的癌症疗法的最佳途径。这些疗法旨在编程免疫系统对抗癌症,使其毒性降低,使其成为一种比化疗和放疗等传统疗法更可持续的选择。
  • 基因治疗和抗体工程联合治疗:另一种混合方法:基因治疗技术与抗体分子工程的结合。用户正在利用载体化输送系统介绍这一新发现,其中经过微调的抗体可以直接在体内表达,因为从技术上讲,它们是经过设计的,可以针对特定的疾病机制。这种混合方法还为生产高选择性、低免疫原性和临床优越性的抗体打开了大门,进一步扩大了载体化抗体市场的范围。
  • 非病毒递送系统日益流行:非病毒递送系统已成为载体化抗体市场的主流。它们在安全性方面优于标准病毒载体。脂质纳米颗粒和 CRISPR-Cas9 基因编辑技术等新兴体内系统已被证明在体内抗体表达中发挥着重要作用。此外,它们可以更好地控制遗传载荷和递送效率以及靶组织,使其成为广泛用于临床的可行候选方案。

用于体内表达的矢量化抗体的市场机会

  • 针对罕见和治疗不足的疾病:载体化抗体是治疗罕见和治疗不足的疾病的绝佳机会,尤其是那些需要高度特异性和定制化抗体疗法的疾病。体内表达可以快速且经济高效地生产治疗性抗体,而这些抗体通常难以大规模生产。对孤儿病的分析可以集中于患者人数少以及与抗体生产相关的传统方法的高成本。
  • 疫苗接种策略的改进:载体化抗体将成为下一代疫苗开发的载体。通过将抗体或抗体片段的表达直接传递给个体,这些载体可以针对几种重要的病原体,包括病毒和细菌,而这些病原体的疫苗接种效果通常会受到影响。这为对传染病(即新出现的病毒感染,如 COVID-19)产生更持久、更强的免疫力提供了机会。
  • 与其他生物制剂的联合疗法:另一种应用包括涉及载体化抗体的联合疗法,例如与免疫检查点抑制剂或 CAR-T 细胞疗法的联合疗法。这些方法可以增强治疗效果,同时促进更全面的治疗模式——尤其是在肿瘤学领域。这些治疗方法被描述为抗体的体内递送,应该可以降低脱靶风险。

 

用于体内表达的矢量化抗体市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响体内表达载体抗体市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的体内表达载体抗体市场细分和地理位置。

Vectorized Antibodies for In Vivo Expression Market
  • 获取体内表达市场矢量化抗体的区域特定数据

用于体内表达的载体抗体市场报告范围

报告属性细节
2023 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2023 - 2031)13.4%
史料2021-2022
预测期2024-2031
涵盖的领域按技术分类
  • 腺相关病毒载体
  • 电穿孔
  • 脂质纳米颗粒
按最终用户
  • 研究所
  • 医院
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 4D分子治疗(4DMT)
  • 艾伯维
  • Adverum 生物技术公司
  • 阿斯利康
  • 生物技术
  • 库雷瓦克
  • 礼来公司
  • 埃特里斯
  • 艾文系统

 

用于体内表达的矢量化抗体市场参与者密度:了解其对业务动态的影响

体内表达载体抗体市场正在快速增长,这得益于最终用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在体内表达载体抗体市场运营的主要公司有:

  1. 4D分子治疗(4DMT)
  2. 艾伯维
  3. Adverum 生物技术公司
  4. 阿斯利康
  5. 生物技术

免责声明上面列出的公司没有按照任何特定顺序排列。


Vectorized Antibodies for In Vivo Expression Market

 

  • 获取用于体内表达的矢量化抗体市场顶级关键参与者概述

 

 

主要卖点

 

  • 全面覆盖:该报告全面涵盖了体内表达市场矢量化抗体的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,关于体内表达载体抗体市场的研究报告可以帮助引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which are some of the players operating in the Vectorized Antibodies for In Vivo Expression market?

Players operating in the market are 4D MOLECULAR THERAPEUTICS (4DMT), ABBVIE, ADVERUM BIOTECHNOLOGIES, ASTRAZENECA, BIONTECH, CUREVAC, ELI LILLY, ETHRIS, EYEVENSYS

Which segment accounts for highest revenue by technology in 2023?

Adenoassociated Virus (AAV) Vector segment, by technology, dominated the market in 2023.

What is the expected CAGR of the Vectorized Antibodies for In Vivo Expression Market?

The Vectorized Antibodies for In Vivo Expression Market is estimated to witness a CAGR of 13.4% from 2023 to 2031

Which region dominated the Vectorized Antibodies for In Vivo Expression market in 2023?

North America region dominated the Vectorized Antibodies for In Vivo Expression market in 2023.

What are the factor that act as a opportunity for market growth?

Target Rare and Underserved Diseases act as a opportunity for growth of the market in forecast period.

What are the driving factors impacting the Vectorized Antibodies for In Vivo Expression market?

The major factors driving the Vectorized Antibodies for In Vivo Expression market are:

1. New Scientific Innovations in Gene Delivery Systems

2. Reduced Manufacturing Costs

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1.4D Molecular Therapeutics (4DMT)
2.AbbVie
3.Adverum Biotechnologies
4.AstraZeneca
5.BioNTech
6.Curevac
7.Eli Lilly
8.Ethris
9.Eyevensys

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.